L Dio 1 Tablet contains Levocetirizine 5mg, a second-generation antihistamine used primarily for the symptomatic relief of allergic conditions. Levocetirizine is the active enantiomer of cetirizine and acts as a selective antagonist of peripheral H1 histamine receptors, thereby inhibiting the effects of histamine, a key mediator in allergic reactions. This medication is indicated for the treatment of allergic rhinitis, including seasonal and perennial types, as well as chronic idiopathic urticaria characterized by itching and hives. Due to its high selectivity and minimal penetration of the blood-brain barrier, Levocetirizine is associated with reduced sedation compared to first-generation antihistamines. L Dio 1 Tablet is typically administered once daily, with or without food, and dosage adjustments may be necessary in patients with renal impairment. Common adverse effects include headache, dry mouth, and fatigue, though it is generally well tolerated. Caution is advised in patients with severe renal dysfunction and in those with a history of hypersensitivity to Levocetirizine or cetirizine. As with all medications, it should be used under medical supervision, and patients are advised to avoid activities requiring mental alertness until they understand how the drug affects them.